Sort
15,842 grants matching “pancreatic cancer”
Engineering the Cancer Microenvironment
$199,271Luis Solorio · Purdue University · R00 · FY2018 · CA
Research Project 1
$199,164Cynthia X Ma · Washington University · U54 · FY2024 · CA
Research Project 2
$199,164Kian H Lim · Washington University · U54 · FY2024 · CA
Clinical trial development in cancer vaccines
$199,105Samir Khleif · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Role of cell cycle withdrawal in restricting pancreatic cancer progression.
$199,078Gregory David · New York University School Of Medicine · R21 · FY2014 · CA
In vivo Image Guided Cancer Therapy
$199,033Anna Moore · Massachusetts General Hospital · R21 · FY2006 · CA
MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases
$199,020Wade M Junker · Sanguine Diagnostics And Therapeutics · R44 · FY2017 · DK
Novel model to study PDAC using normal human pancreatic tissue
$199,013Pei Wang · University Of Texas Hlth Science Center · R21 · FY2017 · CA
Targeting asymmetric ciliary signaling in cancer
$199,013Erica A Golemis · Research Inst Of Fox Chase Can Ctr · R21 · FY2019 · CA
Multi-Modal Gene Therapy for Pancreatic Cancer using Targeted Nanovectors
$199,009Mansoor M. Amiji · Northeastern University · U54 · FY2010 · CA
Chemoprevention of pancreatic cancer witli antidiabetic agents
$198,987Juan Enrique Rozengurt · University Of California Los Angeles · P01 · FY2013 · CA
Assessing pancreatic cancer susceptibility to ceramide-mediated cell death.
$198,950Myles C Cabot · Saint John'S Cancer Institute · R21 · FY2011 · CA
3D Nanoporous microcontainers for cell encapsulation therapy
$198,947David H Gracias · Johns Hopkins University · R21 · FY2008 · EB
Role of Heparan Sulfate-Degrading Sulfatases in Pancreatic Adenocarcinomas
$198,880Steven D Rosen · University Of California, San Francisco · R21 · FY2007 · CA
Environmental Circadian Disruptors Increase Diabetes and Metabolic Disorders Risk
$198,784Margarita L Dubocovich · State University Of New York At Buffalo · R21 · FY2015 · ES
Targeted proteomics to aid in the management of patients with stage IA lung adeno
$198,738Jeffrey A. Borgia · Rush University Medical Center · R21 · FY2019 · CA
Core B - Tissue Procurement, Pathology, and Genomics
$198,679Alina Iuga · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA
Flavonoids in Pancreatic Carcinogenesis & Angiogenesis/Hines, Oscar
$198,494Oscar Joe Hines · University Of California Los Angeles · P01 · FY2010 · AT
MRI: Acquisition of Flow Cytometer Instrument at University of Michigan-Dearborn
$198,401Mathumai Kanapathipillai · Regents Of The University Of Michigan - Ann Arbor · · FY2019 · ENG
Development of Small Molecule Crm-1 Inhibitor for Pancreatic Cancer Therapy
$198,360Ramzi M. Mohammad · Wayne State University · R21 · FY2012 · CA
Treating pancreatic cancer with Listeria-32P
$198,253Claudia Gravekamp · Albert Einstein College Of Medicine, Inc · R21 · FY2015 · CA
The Role of Ire1 in Modulating the Response of Tumors to Hypoxia and Radiation
$198,153Albert Koong · Stanford University · P01 · FY2014 · CA
Clinical protocols for the treatment of gastrointestinal cancer
$198,122Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Pharmacological Impact of 3-Dimensional Extracellular Matrix on Tumor Cells
$198,120Steven A Hayes · Bellbrook Labs, Llc · R43 · FY2009 · CA
Brca1-Mediated Suppression Of Retrotransposon Activity - Resubmission - 1
$198,103Jef D Boeke · New York University School Of Medicine · R21 · FY2021 · CA